Volume 87, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Coinfection with tuberculosis in some countries occurs in 8–15% of human immunodeficiency virus (HIV) -infected patients who have histoplasmosis. This coinfection interferes with prompt diagnosis, and treatment is difficult because of drug interactions. We retrospectively reviewed the cases of 14 HIV-infected patients who had concomitant tuberculosis and histoplasmosis. The most frequent clinical manifestations were weight loss (85.7%), asthenia (78.5%), and fever (64.2%). The diagnosis of histoplasmosis was made primarily by histopathology (71.4%), and the diagnosis of tuberculosis was made by means of direct microscopic examination (71.4%). Death occurred in two patients, and relapse of both infections occurred in one patient. Moxifloxacin was substituted for rifampicin in six patients, with good outcomes noted for both infections. The clinical presentation does not readily identify acquired immunodeficiency syndrome (AIDS) patients who have tuberculosis and histoplasmosis. The use of a fluoroquinolone as an alternative agent in place of rifampicin for tuberculosis allows effective therapy with itraconazole for histoplasmosis.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. World Health Organization, 2006. Global Tuberculosis Control. Available at: http://www.who.int/tb/publications/global_report/2011/gtbr11_full.pdf. Accessed December 2011. [Google Scholar]
  2. McKinsey DS, Spiegel RA, Hutwagner L, Stanford J, Driks MR, Brewer J, Gupta MR, Smith DL, O'Connor MC, Dall L, , 1997. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology. Clin Infect Dis 24: 11951203.[Crossref] [Google Scholar]
  3. Díaz-García MC, León-Mora MW, Hernández D, , 2004. Histoplasmosis diseminada progresiva y tuberculosis en pacientes con SIDA. Medicina Interna (Caracas) 20: 187210. [Google Scholar]
  4. Greene L, Peters B, Lucas SB, Pozniak AL, , 2000. Extrapulmonary tuberculosis masking disseminated histoplasmosis in AIDS. Sex Transm Infect 76: 5456.[Crossref] [Google Scholar]
  5. Jaruratanasirikul S, Sriwiriyajan S, , 1998. Effect of rifampicin on the pharmacokinetics of itraconazole in normal volunteers and AIDS patients. Eur J Clin Pharmacol 54: 155158.[Crossref] [Google Scholar]
  6. Panel on Antiretroviral Guidelines for Adults and Adolescents, 2011. Guidelines for the Use of Antiretroviral Agents in HIV-1–Infected Adults and Adolescents. Department of Health and Human Services. Available at: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed January 10, 2011. [Google Scholar]
  7. Huber F, Nacher M, Aznar C, Pierre-Demar M, El Guedj M, Vaz T, Vantilcke V, Mahamat A, Magnien C, Chauvet E, Carme B, Couppié P, , 2008. AIDS-related Histoplasma capsulatum var. capsulatum infection: 25 years experience of French Guiana. AIDS 22: 10471053.[Crossref] [Google Scholar]
  8. Gutierrez ME, Canton A, Sosa N, Puga E, Talavera L, , 2005. Disseminated histoplasmosis in patients with AIDS in Panama: a review of 104 cases. Clin Infect Dis 40: 11991202.[Crossref] [Google Scholar]
  9. Drayton J, Dickinson G, Rinaldi MG, , 1994. Coadministration of rifampin and itraconazole leads to undetectable levels of serum itraconazole. Clin Infect Dis 18: 266.[Crossref] [Google Scholar]
  10. Piscoya Rivera A, Cedrón Cheng H, Huerta-Mercado Tenorio J, Pinto Valdivia JL, Ferrufino Llach JC, Bussalleu Rivera A, , 2005. GI tuberculosis and histoplasmosis in an HIV (+) patient presenting with lower GI bleeding. Am J Gastroenterol 100: 18961897.[Crossref] [Google Scholar]
  11. Hung MN, Sun HY, Hsueh PR, Hung CC, Chang SC, , 2005. Meningitis due to Histoplasma capsulatum and Mycobacterium tuberculosis in a returned traveler with acquired immunodeficiency syndrome. J Formos Med Assoc 104: 860863. [Google Scholar]
  12. Jeong HW, Sohn JW, Kim MJ, Choi JW, Kim CH, Choi SH, Kim J, Cho Y, , 2007. Disseminated histoplasmosis and tuberculosis in a patient with HIV infection. Yonsei Med J 48: 531534.[Crossref] [Google Scholar]
  13. Rezende RE, Brunaldi MO, Girão MS, Zucoloto S, Garcia SB, Machado AA, Módena JL, , 2009. Case report: esophageal histoplasmosis associated with disseminated tuberculosis in acquired immunodeficiency syndrome. Am J Trop Med Hyg 80: 347350. [Google Scholar]
  14. Wharton M, Chorba TL, Vogt RL, Morse DL, Buehler JW, , 1990. Case definitions for public health surveillance. MMWR Morb Mortal Wkly Rep 39: 3940. [Google Scholar]
  15. Centers for Disease Control and Prevention, 1992. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 41 (RR-17): 119. [Google Scholar]
  16. Zolopa A, Andersen J, Powderly W, Sánchez A, Sanne I, Suckow C, Hogg E, Komarow L, , 2009. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One 4: e5575.[Crossref] [Google Scholar]
  17. Arango M, Castañeda E, Agudelo CI, De Bedout C, Agudelo CA, Tobón A, Linares M, Valencia Y, Restrepo A, The Colombian Histoplasmosis study group, 2011. Histoplasmosis: results of the Colombian national survey, 1992--2008. Biomédica 31: 344356.[Crossref] [Google Scholar]
  18. García I, Merchán A, Chaparro PE, López LE, , 2004. Panorama de la coinfección tuberculosis/VIH en Bogotá. Biomedica 24 (Suppl 1): 132137.[Crossref] [Google Scholar]
  19. Alevritis EM, Sarubbi FA, Jorda RM, Peiris AN, , 2003. Infectious causes of adrenal insufficiency. South Med J 96: 888890.[Crossref] [Google Scholar]
  20. Bravo FG, Gotuzzo E, , 2007. Cutaneous tuberculosis. Clin Dermatol 25: 173180.[Crossref] [Google Scholar]
  21. Tobón AM, Agudelo CA, Rosero DS, Ochoa JE, de Bedout C, Zuluaga A, Arango M, Cano LE, Sampedro J, Restrepo A, , 2005. Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals. Am J Trop Med Hyg 73: 576582. [Google Scholar]
  22. Kirn DH, Fredericks D, McCutchan JA, Stites D, Shuman A, , 1995. Serum ferritin levels correlate with disease activity in patients with AIDS and disseminated histoplasmosis. Clin Infect Dis 21: 10481049.[Crossref] [Google Scholar]
  23. Benedetti MS, , 1995. Inducing properties of rifabutin, and effects on the pharmacokinetics and metabolism of concomitant drugs. Pharmacol Res 32: 177187.[Crossref] [Google Scholar]
  24. Restrepo A, Tobón A, Clark B, Graham DR, Corcoran G, Bradsher RW, Goldman M, Pankey G, Moore T, Negroni R, Graybill JR, , 2007. Salvage treatment of histoplasmosis with posaconazole. J Infect 54: 319327.[Crossref] [Google Scholar]
  25. Hohmann C, Kang EM, Jancel T, , 2010. Rifampin and posaconazole coadministration leads to decreased serum posaconazole concentrations. Clin Infect Dis 50: 939940.[Crossref] [Google Scholar]
  26. Cox H, Ford N, Keshavjee S, McDermid C, von Schoen-Angerer T, Mitnick C, Goemaere E, , 2011. Rational use of moxifloxacin for tuberculosis treatment. Lancet Infect Dis 11: 259260.[Crossref] [Google Scholar]
  27. World Health Organization, 2011. Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. 2011 Update. Geneva: World Health Organization. [Google Scholar]
  28. Dorman SE, Johnson JL, Goldberg S, Muzanye G, Padayatchi N, Bozeman L, Heilig CM, Bernardo J, Choudhri S, Grosset JH, Guy E, Guyadeen P, Leus MC, Maltas G, Menzies D, Nuermberger EL, Villarino M, Vernon A, Chaisson RE, Tuberculosis Trials Consortium; , 2009. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. Am J Respir Crit Care Med 180: 273280.[Crossref] [Google Scholar]
  29. Conde MB, Efron A, Loredo C, De Souza GR, Graça NP, Cezar MC, Ram M, Chaudhary MA, Bishai WR, Kritski AL, Chaisson RE, , 2009. Moxifloxacin in the initial therapy of tuberculosis: a randomized, phase 2 trial. Lancet 373: 11831189.[Crossref] [Google Scholar]
  30. Centers for Disease Control and Prevention, 2003. Treatment of tuberculosis, American Thoracic Society, CDC, and Infectious Diseases Society of America. MMWR Morb Mortal Wkly Rep 52: 180. [Google Scholar]

Data & Media loading...

  • Received : 09 May 2012
  • Accepted : 15 Sep 2012
  • Published online : 05 Dec 2012

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error